DelveInsight’s “Catheter Stabilization Devices Market Insights, Competitive Landscape, and Market Forecast – 2030” report delivers a comprehensive analysis of the Catheter Stabilization Devices market, covering historical and forecasted potential patient pools, competitive landscape and market outlook across the globe through 2030.
Key Takeaways
-
Market size projection: As per DelveInsight’s analysis, the total Catheter Stabilization Devices market size is expected to surge significantly from USD 1.35 billion in 2023 to USD 1.88 billion globally by 2030, representing a CAGR of 6.34% during the forecast period.
-
Patient population data: The report provides a comprehensive analysis of the total Catheter Stabilization Devices potential pool across multiple therapeutic areas, including cardiovascular diseases (over 500 million people globally), respiratory conditions (262 million people with asthma and 392 million with COPD), and neurological disorders (1.8 million people with Multiple Sclerosis globally).
-
Key companies: Leading Catheter Stabilization Devices companies include Baxter International Inc. (NYSE: BAX), Fresenius Medical Care (Xetra: FMEG / NYSE ADR: FMS), NIKKISO CO., LTD. (Tokyo Stock Exchange: 6376), B. Braun Melsungen, Asahi Kasei Corporation (Tokyo Stock Exchange: 3407 / ADR: AHKSY), Infomed SA, Medtronic plc (NYSE: MDT), NxStage Medical (Nasdaq: NXTM), Medica S.p.A. (Euronext Growth Milan / Borsa Italiana: MDC), SWS Hemodialysis Care (Shanghai Stock Exchange: 688410/SHH), Dialco Medical Inc. (subsidiary of Spectral Medical Inc., which is listed on the Toronto Stock Exchange as EDT), Anjue Medical Equipment Co. Ltd, and Jiangxi Sanxin Medtec Co. Ltd. (Shenzhen Stock Exchange: 300453).
-
Product segments: Key catheter stabilization device categories include Arterial Stabilization, Foley Stabilization, Peripheral/CVC Stabilization, Multipurpose Stabilization, and Epidural Stabilization, with multipurpose stabilization expected to demonstrate significant revenue share during the forecast period.
-
B. Braun Medical Inc. announced the launch of its Clik-FIX Epidural/Peripheral Nerve Block (PNB) Catheter Securement Device in January 2025. This represents the latest addition to B. Braun’s Clik-FIX Family of Catheter Securement Devices, specifically designed to reduce catheter displacement and dislodgement risks during regional anesthesia procedures. The device addresses the current lack of universally acknowledged standards for epidural/PNB catheter securement in clinical practice.
-
In February 2024, Cook Medical partnered with Bedal International to add FlexGRIP® catheter securement devices to its percutaneous drainage portfolio. In September 2022, B. Braun Medical Inc. acquired the Clik-FIX catheter securement device portfolio from Starboard Medical.
Recent tariff measures enacted in 2025 have introduced a baseline 10% duty on most Chinese imports affecting catheter stabilization device supply chains, with derivative tariffs of 25% on steel and aluminum components taking effect in March 2025. Know more about how the companies are navigating these tariff tensions @ Catheter Stabilization Devices Recent Developments.
Catheter Stabilization Devices Market Dynamics
The global Catheter Stabilization Devices market demonstrates robust growth momentum, valued at USD 1.35 billion in 2023 and projected to reach USD 1.88 billion by 2030. This substantial market expansion reflects the increasing prevalence of chronic disorders and rising demand for effective medical solutions across clinical and home healthcare settings.
The Catheter Stabilization Devices drivers include the escalating burden of cardiovascular diseases, with over half a billion people globally living with cardiovascular conditions as of 2021. DelveInsight’s analysis projects that over 12 million people will have atrial fibrillation by 2030, necessitating advanced catheter stabilization solutions for diagnostic and therapeutic procedures. Respiratory disorders further amplify market demand, with 262 million people affected by asthma and 392 million living with COPD, particularly impacting low and middle-income countries where three-quarters of COPD patients reside.
Scientific rationale for catheter stabilization devices centers on preventing catheter dislodgement, reducing complications, and ensuring optimal treatment delivery. These devices provide crucial stability during catheter-based interventions such as electrophysiology studies and ablation procedures for atrial fibrillation. For respiratory patients requiring supplemental oxygen or ventilatory support, proper stabilization prevents accidental dislodgement and minimizes patient discomfort.
The Catheter Stabilization Devices clinical development in this space focuses on multipurpose stabilization solutions that offer versatility across diverse medical procedures. These devices demonstrate significant advantages in reducing healthcare costs while enhancing patient safety through reliable catheter securement methods. The multipurpose nature enables seamless integration into both acute and chronic care settings, supporting efficient patient management across various catheterization types.
The Catheter Stabilization Devices competitive landscape features established medical device manufacturers leveraging strategic partnerships and acquisitions to expand their product portfolios. The Catheter Stabilization Devices Companies are focusing on innovative securement technologies that address specific clinical needs while improving patient comfort and treatment outcomes.
According to DelveInsight report, Catheter Stabilization Devices market challenges include potential irritation or allergic reactions from prolonged device use and the availability of alternative procedures. However, the growing aging population, increasing surgical procedures, and expanding home healthcare market present substantial opportunities for market expansion.
Future market outlook remains optimistic, driven by technological advancements in device design, increasing healthcare expenditure, and growing awareness of catheter-related complications. North America is expected to maintain market dominance due to high prevalence of chronic respiratory disorders, rising Parkinson’s disease cases, and increasing cancer incidence requiring catheter-based treatments.
Download the Catheter Stabilization Devices Market report to understand which factors are driving the therapeutic market @ Catheter Stabilization Devices Market Trends.
Catheter Stabilization Devices Targeted Patient Pool
The catheter stabilization devices patient pool spans multiple therapeutic areas across global markets, with significant patient populations requiring catheter-based interventions. Cardiovascular diseases represent the largest patient segment, affecting over 500 million people worldwide, with projections indicating over 12 million people will have atrial fibrillation by 2030. These patients require catheter stabilization during diagnostic procedures, electrophysiology studies, and therapeutic interventions such as ablation procedures.
Respiratory disease epidemiology demonstrates substantial market potential, with 262 million people globally affected by asthma and 392 million living with Chronic Obstructive Pulmonary Disease (COPD). The geographic distribution shows three-quarters of COPD patients residing in low and middle-income countries, indicating significant market expansion opportunities in emerging economies. These patients require catheter stabilization for oxygen delivery systems, ventilatory support, and respiratory monitoring equipment.
Neurological disorders contribute meaningfully to the Catheter Stabilization Devices eligible patient pool, with over 1.8 million people worldwide affected by Multiple Sclerosis. This condition impacts cognitive, emotional, motor, sensory, and visual abilities, necessitating catheter stabilization for urinary catheters and feeding tubes due to muscle weakness and coordination issues. The patient population requires specialized stabilization solutions to prevent catheter dislodgement and minimize complications associated with impaired sensation and motor control.
Regional Catheter Stabilization Devices epidemiological patterns show North America leading in market demand, with over 34 million people living with chronic lung diseases, including asthma and COPD. The United States specifically reports 11.7 million people with chronic respiratory disorders and 14.2 million with COPD as of 2021. Parkinson’s disease affects nearly one million Americans, projected to reach 1.2 million by 2030, with approximately 90,000 new diagnoses annually. Cancer epidemiology further supports market growth, though specific incidence data varies by region and cancer type.
The forecast period from 2024 to 2030 anticipates continued growth in underlying disease prevalence, particularly in aging populations across developed markets. This demographic trend, combined with expanding healthcare access in emerging markets, supports sustained demand for catheter stabilization devices across diverse patient populations and clinical applications.
Discover evolving trends in the Catheter Stabilization Devices patient pool forecasts @ Catheter Stabilization Devices Patient Pool Analysis.
Key Catheter Stabilization Devices Companies and Treatment Market
The catheter stabilization devices market operates within a well-established clinical and regulatory framework, supporting diverse treatment modalities across hospital and home healthcare settings. Current treatment options encompass multiple device categories, including arterial stabilization, Foley stabilization, peripheral/CVC stabilization, multipurpose stabilization, and epidural stabilization systems. These devices serve critical roles in preventing catheter migration, reducing infection risks, and improving patient comfort during both short-term and long-term catheterization procedures.
The Catheter Stabilization Devices clinical pipeline activity demonstrates robust development phases with ongoing studies focusing on enhanced biocompatibility, improved adhesion mechanisms, and innovative securement technologies. Companies are advancing multipurpose stabilization platforms that offer versatility across multiple catheter types while reducing inventory complexity for healthcare providers. Development programs emphasize patient safety improvements, cost-effectiveness, and integration with existing clinical workflows.
Key Catheter Stabilization Devices companies include Baxter (comprehensive infusion and renal care solutions), Fresenius Medical Care AG & Co. KGaA (dialysis and nephrology focus), NIKKISO CO., LTD. (medical device technologies), B. Braun Melsungen AG (infusion therapy and pain management), Asahi Kasei Corporation (diversified medical technologies), Infomed SA (specialized medical devices), Medtronic (broad medical device portfolio), NxStage Medical, Inc. (kidney care solutions), Medica S.p.A. (dialysis equipment), SWS Hemodialysis Care Co., Ltd. (renal care), Dialco Medical Inc. (dialysis solutions), Anjue Medical Equipment Co. Ltd (medical equipment manufacturing), and Jiangxi Sanxin Medtec Co. Ltd (medical device production).
Market positioning reflects the critical role these devices play in current treatment paradigms, particularly for patients with chronic conditions requiring long-term catheter access. Companies leverage their existing relationships with healthcare providers and distribution networks to expand catheter stabilization device adoption. The devices integrate seamlessly with established clinical protocols while offering measurable improvements in patient outcomes and healthcare economics.
Furthermore, Catheter Stabilization Devices development milestones include strategic partnerships and acquisitions that enhance product portfolios and market reach. Cook Medical’s February 2024 partnership with Bedal International brought FlexGRIP® catheter securement devices into their percutaneous drainage portfolio, demonstrating industry consolidation trends. B. Braun Medical Inc.’s September 2022 acquisition of the Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. exemplifies companies’ focus on innovative securement technologies.
Commercial arrangements increasingly feature licensing deals and strategic collaborations that combine complementary technologies and expand market access. These partnerships enable companies to leverage specialized expertise while accelerating product development timelines and reducing regulatory burdens. The collaborative approach supports innovation in device design while maintaining focus on clinical efficacy and patient safety.
Delve deeper into the major and specialised companies in the Catheter Stabilization Devices market @ Catheter Stabilization Devices Competitive Landscape.
Conclusion
The catheter stabilization devices market represents a dynamic and rapidly expanding segment of the global medical device industry, driven by the increasing prevalence of chronic diseases and the growing demand for effective catheter management solutions. With a projected market growth from USD 1.35 billion in 2023 to USD 1.88 billion by 2030, this sector demonstrates strong fundamentals supported by robust patient populations across cardiovascular, respiratory, and neurological therapeutic areas. The market’s evolution reflects the critical importance of catheter stabilization in modern healthcare delivery, offering significant opportunities for innovation, strategic partnerships, and market expansion across both established and emerging healthcare markets.
Table of Contents
1. Catheter Stabilization Devices Market Report Introduction
2. Catheter Stabilization Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Catheter Stabilization Devices Market Key Factors Analysis
6. Catheter Stabilization Devices Market Porter’s Five Forces Analysis
7. Catheter Stabilization Devices Market Assessment
8. Catheter Stabilization Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading business consulting and market research company focused on the healthcare and life sciences sectors, providing comprehensive market intelligence, competitive landscape analysis, and strategic insights to support decision-making across the pharmaceutical industry.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/